Profound Medical Corp.
PROF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $147,211 | $177,314 | $174,843 | $193,539 |
| - Cash | $24,826 | $35,195 | $46,433 | $54,912 |
| + Debt | $277 | $4,813 | $4,883 | $5,121 |
| Enterprise Value | $122,662 | $146,932 | $133,293 | $143,748 |
| Revenue | $5,230 | $2,211 | $2,621 | $5,327 |
| % Growth | 136.6% | -15.6% | -50.8% | – |
| Gross Profit | $3,887 | $1,618 | $1,853 | $3,629 |
| % Margin | 74.3% | 73.2% | 70.7% | 68.1% |
| EBITDA | -$7,624 | -$13,665 | -$11,003 | -$12,055 |
| % Margin | -145.8% | -618% | -419.8% | -226.3% |
| Net Income | -$7,889 | -$15,695 | -$10,724 | -$7,669 |
| % Margin | -150.8% | -709.9% | -409.2% | -144% |
| EPS Diluted | 0.26 | -0.52 | -0.36 | -0.19 |
| % Growth | 150% | -44.4% | -89.5% | – |
| Operating Cash Flow | -$9,480 | -$14,069 | -$8,283 | -$5,642 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$9,480 | -$14,069 | -$8,283 | -$5,642 |